In a precedential opinion issued on March 6, the Federal Circuit affirmed the US District Court for the Eastern District of ...

Oxford BioTherapeutics (OBT) has entered a multi-year partnership with Roche to discover antibody-based therapeutics for ...

Retail pharmacies are seeing heavy change and restructuring, influencing health care M&A. “Health care providers are ...

Background: ImmunoGen’s Patent Application & Dispute. In 2014, ImmunoGen, Inc. (Immunogen) filed U.S. Patent Application No.

ImmunoGenAlmost four years after backing out of an antibody-drug conjugate (ADC) alliance with ImmunoGen, Eli Lilly has come back to the table with a new, wide-ranging deal worth up to $1.7 billion.

Roche, which put billions on the line a year ago across several ADC pacts, kicked off 2025 by returning to Innovent Biologics ...

Duska noted that the PD-L1 inhibitor pembrolizumab has shown efficacy in the treatment of recurrent or metastatic cervical ...

In a precedential opinion issued on March 6, the Federal Circuit affirmed the US District Court for the Eastern District of Virginia that the claims in ImmunoGen’s US patent application 14/ ...

Oxford BioTherapeutics (OBT) has lined up another big pharma partner for its drug discovery platform, agreeing to work with ...

消息面上，美联储决定维持基准利率在4.25%~4.50%区间内不变，符合市场预期。鲍威尔认为美国经济仍然强劲，但调查显示经济不确定性加剧，不确定性将如何影响经济前景还有待观察。他补充称，劳动力市场状况稳固，失业率处于窄幅区间；通胀已取得进展，但仍高于 ...

Oxford BioTherapeutics (OBT), a clinical-stage oncology firm, has announced a long-term partnership with Roche ...

A new precision oncology paper was published in Oncotarget, Volume 16, on March 12, 2025, titled “Worldwide Innovative ...